Literature DB >> 19508590

Impaired endothelial- and nonendothelial-mediated vasodilation in patients with acute or chronic hypothyroidism.

Raffaele Napoli1, Vincenzo Guardasole, Emanuela Zarra, Carolina D'Anna, Antonietta De Sena, Gelsy Arianna Lupoli, Ugo Oliviero, Margherita Matarazzo, Giovanni Lupoli, Luigi Saccà.   

Abstract

OBJECTIVE: Vascular dysfunction and accelerated atherosclerosis are prominent features of hypothyroidism. The relative roles of thyroid hormone (TH) deficiency and the associated vascular risk conditions are still unclear. We studied the impact of acute and chronic hypothyroidism on vascular reactivity. PATIENTS: We studied 12 patients with chronic primary hypothyroidism (cHY; TSH: 52 +/- 14 mU/l), seven patients with acute hypothyroidism secondary to total thyroidectomy (aHY; TSH: 97 +/- 24) and 13 healthy subjects (TSH: 1.2 +/- 0.5). MEASUREMENTS: We measured forearm blood flow (FBF) using plethysmography during intra-brachial infusion of: acetylcholine (ACh), sodium nitroprusside (NP) and norepinephrine (NE). We also measured serum C-reactive protein (CRP), TNF-alpha, asymmetric dimethylarginine (ADMA) and the forearm balance of nitric oxide (NO) during ACh infusion.
RESULTS: As compared with the controls, the vasodilatory response to ACh was reduced in cHY (P = 0.001) and aHY (P = 0.04), as was the forearm release of NO (P < 0.05). During NP infusion, FBF rose to 24 +/- 2 ml/dl/min in the controls and to significantly lower values in cHY (12 +/- 1; P = 0.001) and aHY (15 +/- 2; P = 0.004). NE-induced vasoconstriction was similar in the controls and aHY, but blunted in cHY. Serum CRP, TNF-alpha and ADMA were not different in the three groups.
CONCLUSIONS: (i) Hypothyroidism associates with endothelial and nonendothelial mediated vascular dysfunction; (ii) these defects are evident even after short-term hypothyroidism, indicating that TH deficiency per se is sufficient to alter vascular homeostasis; and (iii) chronic, but not acute, hypothyroidism impairs the vasoconstrictory effect of NE in the resistance vessels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508590     DOI: 10.1111/j.1365-2265.2009.03609.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  The evaluation and treatment of endocrine forms of hypertension.

Authors:  Alejandro Velasco; Wanpen Vongpatanasin
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

2.  Effect of nitrate and L-arginine therapy on nitric oxide levels in serum, heart, and aorta of fetal hypothyroid rats.

Authors:  Asghar Ghasemi; Fatemeh Mehrazin; Saleh Zahediasl
Journal:  J Physiol Biochem       Date:  2013-04-09       Impact factor: 4.158

3.  The primary vascular dysregulation syndrome: implications for eye diseases.

Authors:  Josef Flammer; Katarzyna Konieczka; Andreas J Flammer
Journal:  EPMA J       Date:  2013-06-07       Impact factor: 6.543

4.  Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism.

Authors:  Mehmet Gunduz; Ercan Gunduz; Fatih Kircelli; Nazan Okur; Mesut Ozkaya
Journal:  Int J Endocrinol       Date:  2012-02-23       Impact factor: 3.257

5.  Subclinical hypothyroidism or thyroid autoimmunity and variant angina: by chance? Or with a chance?

Authors:  In Sook Kang; Wook Bum Pyun
Journal:  Korean Circ J       Date:  2015-03-24       Impact factor: 3.243

6.  Free triiodothyronine in relation to coronary severity at different ages: Gensini score assessment in 4206 euthyroid patients.

Authors:  Bing-Yang Zhou; Yuan-Lin Guo; Na-Qiong Wu; Cheng-Gang Zhu; Ying Gao; Ping Qing; Xiao-Lin Li; Yao Wang; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Geriatr Cardiol       Date:  2016-12       Impact factor: 3.327

7.  Congenital hypothyroidism presenting with reversible renal impairment: an under-recognised problem?

Authors:  Leïla Essaddam; Asma Ben Mansour; Nada Missaoui; Rahma Guedri; Nadia Mattoussi; Zohra Fitouri; Saayda Ben Becher
Journal:  J Diabetes Metab Disord       Date:  2019-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.